NCT06860919

Brief Summary

A transition consultation for adult patients with esophageal atresia, involving medical and paramedical stakeholders, was set up at Hôpital Saint-Louis in 2020. The aim of this initiative is to: 1. initiate adult medical, psychological and social follow-up; 2. empower these adults in their future care; 3. establish a personalized follow-up schedule. This project is the first to focus on post-traumatic stress disorder (PTSD) in young adults with esophageal atresia. A 3-year analysis of the somatic and psychosocial variables analyzed will confirm the validity of this initiative, and define its optimal contours for improving these patients' quality of life as adults.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
56mo left

Started Dec 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Dec 2024Dec 2030

Study Start

First participant enrolled

December 19, 2024

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

January 16, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 6, 2025

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2030

Last Updated

March 6, 2025

Status Verified

January 1, 2025

Enrollment Period

6 years

First QC Date

January 16, 2025

Last Update Submit

February 28, 2025

Conditions

Keywords

Esophageal Atresia

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Post Traumatic Stress Disorder

    At day 0

Secondary Outcomes (18)

  • Hospital Anxiety and Depression score

    At day 0

  • Hospital Anxiety and Depression score

    At 3 years

  • Quality of life evaluation

    At day 0

  • Quality of life evaluation

    At 3 years

  • Eating assessment

    At day 0

  • +13 more secondary outcomes

Study Arms (1)

Young adults with esophageal atresia

Other: Follow-up of the patients during 3 years

Interventions

Evaluation of PTSD prevalence, anxiety-depressive state, quality of life, look for a correlation between their clinical history and PTSD. Analysis of the nutritional, gastrointestinal and respiratory status.

Young adults with esophageal atresia

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Young adults with esophageal atresia

You may qualify if:

  • Patients with esophageal atresia
  • Aged 18 to 30
  • Followed at Hôpital Saint Louis
  • Informed and not opposed to the study
  • Patients affiliated to a social security scheme

You may not qualify if:

  • Inability to answer questionnaires
  • Patients under guardianship
  • Patients under AME (Aide Médicale d'Etat in France)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Saint Louis

Paris, France

RECRUITING

MeSH Terms

Conditions

Esophageal Atresia

Condition Hierarchy (Ancestors)

Digestive System AbnormalitiesDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Pierre Cattan, MD PhD

CONTACT

Jérôme Lambert, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2025

First Posted

March 6, 2025

Study Start

December 19, 2024

Primary Completion (Estimated)

December 19, 2030

Study Completion (Estimated)

December 19, 2030

Last Updated

March 6, 2025

Record last verified: 2025-01

Locations